Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Inda Filho, Antonio Jose ^a   Caixeta, Adriano ^b   Manggini, Marcia ^a   Schor, Nestor ^c  

^a HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CREATININE; CYSTATIN C; IOXITALAMIC ACID; CONTRAST MEDIUM; IOTALAMIC ACID;

ACUTE KIDNEY FAILURE; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BRONCHOSPASM; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; FEMALE; HEADACHE; HEART VENTRICULOGRAPHY; HUMAN; INCIDENCE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSMOLALITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RASH; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; CHEMISTRY; DIAGNOSTIC USE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OSMOLARITY;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ADMINISTRATION, INTRAVENOUS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; IOTHALAMIC ACID; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; SODIUM BICARBONATE;

EID: 84907455468     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107602     Document Type: Article

References (65)

1. MacCullough PA (2008) Contrast-induced acute kidney injury. J Am Coll Cardiol 51(15): 1419-1428.
2. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, et al. (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320(3): 143-149.
3. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, et al. (1999) A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. study. Prevention of radiocontrast induced nephropathy clinical evaluation. J Am Coll Cardiol 33(2): 403-411.
4. Solomon R, Werner C, Mann D, D'Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416-1420.
5. Brown JR, Block CA, Malenka DJ, O'Connor GT, Schoolwerth AC, et al. (2009) Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Intverv 2(11): 1116-1124.
6. Mehran R, Caixeta A (2010) N-acetylcysteine in preventing contrast-induced nephropathy. To give, or not to give: that is the question. Rev Esp Cardiol 63(1): 9-11.
7. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127(1): e6-e245. Available: http://circ.ahajournals.org/content/127/1/e6.full.pdf+html. Accessed: 2014 Aug 29.
8. Nikolsky E, Mehran R (2003) Understanding the consequences of contrast-induced nephropathy. Rev Cardiovasc Med (Suppl. 5): S10-18.
9. Barreto R (2007) Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate. Nephrol Nurs J 34(4): 417-421.
10. McCullough PA, Sandberg KR (2003) Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med (Suppl. 5): S3-S9.
11. Choudhury D (2010) Acute kidney injury: current perspectives. Postgrad Med 122(6): 29-40.
12. Ellis HE, Cohan RH (2009) Prevention of contrast-induced nephropathy: an overview. Radiol Clin North Am 47(5): 801-811.
13. Heng AE, Cellarier E, Aublet-Cuvelier B, Decalf V, Motreff P, et al. (2008) Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date? Clin Nephrol 70(6): 475-484.
14. Thiele H, Hildebrand L, Schirdewahn C, Eitel I, Adams V, et al. (2010) Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate Percutaneous Coronary Intervention Acute Myocardial Infarction N-ACC) Trial. J Am Coll Cardiol 55(20): 2201-2209.
15. Sun Z, Fu Q, Cao L, Jin W, Cheng L, et al. (2013) Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLOS One 8(1): e55124. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0055124. Accessed: 2014 Aug 29.
16. Kwok CS, Pang CL, Yeong JK, Loke YK (2013) Measures used to treat contrast-induced nephropathy: overview of reviews. Br J Radiol 86(1021): 20120272.
17. Droppa M, Desch S, Blase P, Eitel I, Fuernau G, et al. (2011) Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol 100(11): 1037-1043.
18. Henry RJ, Cannon DC, Winkelman NJW (1974) Clinical chemistry: Principles and technics. 2nd ed. New York: Harper & Row.
19. Finney H, Newman DJ, Gruber W, Merle P, Price CP (1997) Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 43(6): 1016-1022.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6): 461-470.
21. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, et al. (2008) Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51(3): 395-406.
22. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Supplement 2: 69-88.
23. Ribichini F, Gambaro G, Graziani MS, Pighi M, Pesarini G, et al. (2012) Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clinical Chemistry 58(2): 458-464.
24. Webb JG, Pate GE, Humphries KH, Buller CE, Shalansky S, et al. (2004) A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am HeartJ 148: 422-429.
25. Carbonell N, Blasco M, Sanjuán R, Pérez-Sancho E, Sanchis J, et al. (2007) Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomized trial. Int J Cardiol 115: 57-62.
26. Kefer JM, Hanet CE, Boitte S, Wilmotte L, De Kock M (2003) Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient? Acta Cardiol 58: 555-560.
27. Poletti PA, Saudan P, Planton A, Mermillod B, Sautter AM, et al. (2007) IV N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. Am J Roentgenol 189: 687-692.
28. Rashid ST, Salman M, Myint F, Baker DM, Agarwal S, et al. (2004) Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine. J Vasc Surg 40: 1136-1141.
29. Jaffery Z, Verma A, White CJ, Grant AG, Collins TJ, et al. (2012) A randomized trial of intravenous N-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. Catheter Cardiovasc Interv 6: 921-926.
30. Adolph E, Holdt-Lehmann B, Chatterjee T, Paschka S, Prott A, et al. (2008) Renal Insufficiency Following Radiocontrast Exposure trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coron Artery Dis: 19: 413-419.
31. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, et al. (2008) Sodium bicarbonate versus saline for prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol. 52: 599-604.
32. Schmidt P, Pang D, Nykamp D, Knowlton G, Jia H (2007) N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Ann Pharmacother 41: 46-50.
33. Hafiz AM, Jan MF, Mori N, Shaikh F, Wallach J, et al. (2012) Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of preventive strategies. Catheter Cardiovasc Interv 79(6): 929-937.
34. Ueda H, Yamada T, Masuda M, Okuyama Y, Morita T, et al. (2011) Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing coronary procedures. Am J Cardiol 107(8): 1163-1167.
35. Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, et al. (2012) Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury - a systematic review and meta-analysis. Circ J 9: 2255-2265.
36. Merten GB, Burgess WP, Gray LV, Holleman JH, Roush TS, et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291: 2328-2334.
37. Backer CS, Wragg A, Kumar S, De Palma R, Baker LR, et al. (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41: 2114-2118.
38. Briguori C, Arioldi F, D'Andrea D, Bonizzoni E, Morici N, et al. (2007) Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115: 1211-1217.
39. Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, et al. (2007) The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO study. J Am Coll Cardiol 49: 1283-1288.
40. Leone A, De Catarina A, Sciahbasi A, Aurelio A, Basile E, et al. (2012) Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (Bicarbonato e N-acetil-cisteina nell'infaRto miocardico acuto) study. Euro Intervention 7: 839-847.
41. Brown JR, Block CA, Malenka DJ, O'Connor GT, Schoolwerth AC, et al. (2009) Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Interv. 2(11): 1116-1124.
42. Fishbane S (2008) N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 3: 281-287.
43. Caulfield JL, Singh SP, Wishnok JS, Deen WM, Tannenbaum SR, et al. (1996) Bicarbonate Inhibits N-nitrosation in oxygenated nitric oxide solutions. J Biol Chem 271(42): 25859-25863.
44. Herget-Rosenthal S, Marggraf G, Husing J, Göring F, Pietruck F, et al. (2004) Early detection of acute renal failure by serum cystatin C. Kidney Int 66: 1115-1122.
45. Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, et al. (2010) Cystatin C and contrast-induced acute kidney injury. Circulation 2010; 121: 2117-2122.
46. Newhouse JH, Kho D, Rao QA, Starren J (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191: 376-382.
47. Chao CT (2013) Epidemiology, clinical features and diagnosis of contrast induced nephropathy: a brief review. General Med 1: 102.
48. Fricker M, Wiesli P, Brändle M, Schwegler B, Schmid C (2003) Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63(5): 1944-1947.
49. McMahon GM, Waikar SS (2013) Biomarkers in nephrology: core curriculum 2013. Am J Kidney Dis 62(1): 165-178.
50. Barret BJ, Carlisle EJ (1993) Meta-analysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 188: 171-178.
51. Rudnick MR, Goldforbs S, Wexler L, Ludbrook PA, Murphy MJ, et al. (1995) Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47: 254-261.
52. Ad-hoc working group of ERBP, Fliser D, Laville M, Covic A, Fouque D, et al. (2012) A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: Part 1: Definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 27(12): 4263-4272.
53. James M, Bouchard J, Ho J, Klarenbach S, LaFrance JP, et al. (2013) Canadian society of nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 5: 673-685.
54. Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, et al. (2004) N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15(3): 761-769.
55. Zagler A, Azadpour M, Mercado C, Hennekens CH (2006) N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 151(1): 140-145.
56. ACT Investigators (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-Induced Nephropathy trial (ACT). Circulation 124(11): 1250-1259.
57. Chertow GM, Palevsky PM, Greene T (2006) Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician. Clin J Am Soc Nephrol 1(4): 1124-1127.
58. Reddan D, Laville M, Garovic VD (2009) Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings? J Nephrol 22(3): 333-351.
59. Hollis S, Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319: 670-674.
60. Keirse MJNC, Hanssens M (2000) Control of error in randomised clinical trials. Eur J Obstet Gynecol Reprod Biol 92: 67-74.
61. Schultz KF, Grimes DA (2002) Sample size slippages in randomised controlled trials: exclusions and the lost and wayward. Lancet 359: 781-785.
62. Rubin DB (1987) Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons.
63. van Buuren S (2012) Flexible imputation of missing data. Boca Raton: CRC Press.
64. Bellomo R, Ronco C, Kellum JA, Mehta RL (2004) Acute Dialysis Quality Initiative workgroup: acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-R212.
65. McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, et al. (2013) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267(1): 106-118.